Health ❯COVID-19 ❯Vaccines

Effectiveness

JN.1 Symptomatic Infection Severe Symptoms Symptomatic Infections JN.1 Subvariant Symptomatic disease

CDC Study Finds Updated COVID-19 Vaccine 54% Effective